Bath & Body Works, Inc. (NYSE: BBWI) – the specialty retailer known for soaps, fragrances, and home aroma products – faces a critical juncture as a key date in March 2026 looms. With the March 16, 2026 deadline approaching (coinciding with anticipated year-end results and shareholder actions), investors are evaluating the company’s fundamentals and risks. Below we dive into BBWI’s dividend policy, leverage, coverage ratios, valuation, and the risks/red flags that warrant attention (www.sec.gov) (www.sec.gov). This structured analysis is grounded in first-party filings and credible financial sources.

Don't wait — first dividend checks could arrive any day.

Get the concise guide to start collecting royalty checks now.

Get Instant Access
✕

Dividend Policy & Yield

Resumption and Growth of Dividends: Bath & Body Works suspended its dividend in 2020 amid COVID-19 uncertainty, but the Board reinstated a quarterly dividend in March 2021 at an annual rate of $0.60 per share (www.sec.gov) (www.sec.gov). The payout was subsequently raised to $0.80 per share annually in early 2022, reflecting confidence in cash flows post-pandemic (www.sec.gov). Since then, BBWI has maintained a steady $0.20 per share quarterly dividend, including each quarter of 2023 (www.sec.gov). This consistent dividend indicates a commitment to returning capital to shareholders.

Dividend Yield and Payout: At recent share prices in the low-$20s, Bath & Body Works’ dividend yield stands around 3.5%–4% (dividendpedia.com). For example, with the stock near $23/share in early 2026 (dividendpedia.com) and a $0.80 annual dividend, the yield is about 3.5%. Notably, the dividend remains well-covered by earnings – the payout ratio is under 25% of 2023 profits (dividendpedia.com) – and by free cash flow (in 2023, dividends of ~$182 million were easily met by $954 million in operating cash flow (www.sec.gov)). Such low payout levels give BBWI flexibility to continue dividends even if earnings fluctuate. (AFFO/FFO metrics are not applicable here, as BBWI is not a REIT; instead, net income and free cash flow provide the relevant coverage benchmarks.)

Capital Returns Beyond Dividends: In addition to dividends, Bath & Body Works actively repurchases shares when prudent. Over 2022–2023 it bought back stock (~$148 million in 2023 and $300+ million in 2022) while also retiring debt (www.sec.gov) (www.sec.gov). In fact, the Board authorized a new $500 million share repurchase program in January 2024 as a signal of confidence (www.sec.gov) (www.sec.gov). These buybacks, alongside the 3–4% dividend yield, underscore an overall shareholder yield that is quite attractive. The key question is whether this capital return strategy is sustainable without compromising growth investments or balance sheet health – which ties into the leverage discussion below.

Leverage & Debt Maturities

Debt Profile: BBWI carries a substantial debt load, a legacy of its separation from L Brands and subsequent financing needs. As of fiscal year-end 2023 (Feb 3, 2024), total long-term debt was $4.39 billion (down from $4.86 billion a year earlier) (www.sec.gov) (www.sec.gov). The debt is entirely fixed-rate, which locks in interest costs and shields the company from rising rate volatility (www.sec.gov). However, many of the notes were issued at high coupons reflecting non-investment-grade credit ratings. For instance, BBWI has a $314 million note at 9.375% due July 2025 and a $297 million note at 6.694% due January 2027 (www.sec.gov). Additional tranches include $462 million of 5.25% notes due 2028 and roughly $2.85 billion of 6.6%–7.6% notes maturing 2029 through 2037 (www.sec.gov). This means the weighted interest rate on debt is relatively high (around ~7%), creating a significant interest expense burden (discussed under coverage). On a positive note, no debt maturities occur in 2024, and near-term obligations are modest – $314 million due in 2025 and $297 million in 2026, with the vast majority (over $3.3 billion) not due until 2028 or later (www.sec.gov). This staggered maturity schedule gives the company breathing room to manage refinancing.

Liquidity and Balance Sheet: Bath & Body Works had $1.08 billion in cash on hand at the end of 2023 (www.sec.gov) (www.sec.gov), providing a solid liquidity cushion. It also maintains a $750 million asset-backed credit facility (ABL), which was undrawn as of the latest report and available for working capital if needed (www.sec.gov) (www.sec.gov). This ABL revolver expires in August 2026 (www.sec.gov), roughly aligning with the timeline of the approaching deadline. As of Feb 2024, BBWI had ~$529 million of borrowing capacity on the facility (after reserving ~$10 million for letters of credit) (www.sec.gov) (www.sec.gov). Importantly, the ABL includes a springing covenant that requires a fixed-charge coverage ratio ≥1.0× if availability falls too low (www.sec.gov) – essentially ensuring BBWI cannot overextend itself without sufficient earnings cover. Overall, net debt (debt minus cash) sits near $3.3 billion, which is about 2.5× 2023 EBITDA – a moderate leverage ratio for a stable retail business and one that rating agencies have rated in the “Ba” (non-investment grade) category (Moody’s upgraded BBWI to Ba2 in 2022, outlook stable). Management has used excess cash to deleverage opportunistically – in 2023, the company repurchased $485 million of its outstanding notes on the open market at a discount, reducing debt by $474 million and recognizing a $34 million pre-tax gain (www.sec.gov) (www.sec.gov). Going forward, investors will watch how BBWI balances further debt reduction (especially the pricey 9.375% notes due 2025) against other capital priorities like buybacks.

Maturity “Deadline” – March 2026 Context: The “deadline” in March 2026 likely alludes to time-sensitive financial events. By that date, Bath & Body Works will need to address its July 2025 notes (either through refinancing or repayment) and possibly outline plans for the January 2027 notes coming due in the following fiscal year. The company’s full-year 2025 earnings report and guidance (expected around mid-March 2026) will be a critical juncture for management to update shareholders on these debt plans. In short, BBWI’s leverage is manageable but not trivial – the company must act proactively to refinance or pay down upcoming maturities, especially given the high coupon rates. Successful navigation of the 2025–2026 debt hump, without eroding shareholder returns, will be key to sustaining investor confidence.

Coverage Ratios (Interest & Dividend Coverage)

Interest Coverage: Bath & Body Works generates healthy operating profits that comfortably cover its interest obligations – but the margin of safety isn’t as large as some less-levered peers. In fiscal 2023, operating income was $1.285 billion while interest expense was $345 million (www.sec.gov) (www.sec.gov). This yields an EBIT/interest coverage ratio of roughly 3.7×, meaning BBWI earned nearly four times its interest cost in operating profit. On an EBITDA basis (adding back $269 million of depreciation), coverage is higher at ~4.8× (www.sec.gov) (www.sec.gov). These figures indicate that while debt service is being met with room to spare, interest eats up a notable share of earnings (for context, interest expense equaled ~39% of net income in 2023). The company’s fixed-rate debt structure ensures interest costs won’t rise in the short term, but BBWI does remain sensitive to earnings declines – a downturn in sales or margins could tighten coverage. It’s worth noting management must maintain at least a 1.0× fixed-charge coverage (including rent obligations) under the ABL covenant if liquidity draws down (www.sec.gov) (www.sec.gov), a threshold the company easily exceeds today. Overall, interest coverage is solid but not excessive, reflecting BBWI’s mid-level leverage.

Dividend Coverage: BBWI’s dividend appears very well-covered by both earnings and cash flow. As mentioned, the payout ratio was ~20–25% of earnings in 2023 (dividendpedia.com) – in other words, only a quarter of net profit was paid out as dividends. Free cash flow coverage is similarly robust: after capital expenditures, Bath & Body Works generated roughly $668 million in free cash in 2023 (operating cash $954 M minus investing $286 M) (www.sec.gov), whereas cash dividends consumed about $182 million (www.sec.gov). That’s a coverage of 3.5× by free cash flow, indicating the dividend could be sustained even if earnings faced temporary pressure. In 2024, the company actually increased its dividend payments (four quarters at $0.20 versus three in the prior year) as operations stabilized (www.sec.gov). Unless BBWI embarks on significantly higher capital spending or experiences a sharp profit drop, the dividend should remain comfortably covered. Dividend safety metrics (coverage ratios) thus reinforce that the current $0.80/year payout is not at risk – indeed, the Board’s willingness to concurrently authorize large share buybacks implies confidence that cash generation will exceed all internal needs and shareholder distributions.

Valuation & Comparable Metrics

Earnings Valuation: Bath & Body Works stock trades at a low earnings multiple relative to both the broad market and retail peers. Based on fiscal 2023 results, BBWI’s trailing P/E ratio is roughly 6×–7× (using adjusted EPS of $3.27 and a recent share price around $23) (www.sec.gov) (dividendpedia.com). Even looking forward, the company’s 2024 guidance is $3.15–$3.28 in EPS (apnews.com), and consensus analyst forecasts center around ~$3.20 (apnews.com). With the stock in the low-$20s, that implies a forward P/E of about 7× – a steep discount to the S&P 500 (~15×) and to high-quality specialty retailers. This discounted valuation suggests the market has low growth expectations or elevated risk concerns (discussed further in Risks). It may also reflect BBWI’s leveraged balance sheet and the fact that 2023 earnings were flattered by one-time gains (e.g. ~$0.15/share from debt extinguishment) (www.sec.gov). Even adjusting for that, the valuation is cheap relative to Bath & Body Works’ historical multiples when it was part of L Brands.

Cash Flow and EV/EBITDA: On an enterprise value basis, BBWI also looks inexpensive. The stock’s market cap is about $5.0–$5.5 billion at current prices, and including $3.3 billion net debt yields an enterprise value (EV) around $8.3–$8.8 billion. Compared to ~$1.56 billion in 2023 EBITDA (operating income plus $269 M depreciation) (www.sec.gov), the EV/EBITDA multiple is roughly 5.5×. For a stable brand with double-digit operating margins and strong free cash conversion, an EV/EBITDA in the mid-single-digits is arguably low. By comparison, peer retailers with strong franchises trade at higher valuations: for instance, Ulta Beauty (a larger beauty retailer with no debt) has historically traded closer to ~12× EV/EBITDA and mid-to-high teens P/E, reflecting its growth profile. Even Victoria’s Secret (BBWI’s former sister company, ticker VSCO) – which has struggled – recently traded around 5× EV/EBITDA, but that accompanied much lower margins and no dividend. Bath & Body Works’ combination of solid profitability, cash returns, and low multiples could signal a potential value opportunity if the business can achieve even modest growth. Notably, BBWI’s Board and management appear to view the stock as undervalued, given their ongoing share repurchases and a new $500 MM buyback authorization in 2024 (www.sec.gov) (www.sec.gov). For value-oriented investors, the key question is whether the market’s caution is overdone or justified by risks – which we explore next.

Risks & Red Flags

Despite its strong brand and cash generation, Bath & Body Works faces several risks and red flags that investors should weigh carefully:

– Steep Seasonality & Holiday Reliance: The company’s sales and profits are heavily skewed toward the holiday-driven fourth quarter. BBWI typically earns a disproportionate share of its operating income in Q4 each year (www.sec.gov) (www.sec.gov) (the holiday season accounts for ~40% of annual sales and an even higher share of profit). This means any misstep during the holiday period – such as weak consumer spending, bad product assortment, or supply chain snafus – could materially impact full-year results (www.sec.gov). The shorter holiday calendar in some years (as noted by management (apnews.com)) and volatile retail environment add to this risk. A poor holiday season would not only dent earnings but could also lead to elevated inventory and markdowns. In 2022–2023, Bath & Body Works navigated holiday challenges well (Q4 results have generally met or beat forecasts (apnews.com)), but investors remain wary of the company’s exposure to seasonal swings.

– Consumer Trends & Competition: Bath & Body Works must continuously adapt to changing consumer preferences in fragrances, personal care, and home décor. The brand has benefited from product innovation and savvy marketing – e.g. launching new scents, seasonal collections, and tie-ins like a Stranger Things themed line to spur excitement (apnews.com). However, the flip side is that fickle consumer tastes could render some collections less successful, requiring heavy promotions. Competition is also a concern: while BBWI is a leader in its niche, it competes indirectly with beauty retailers (Ulta, Sephora), specialty candle/fragrance makers, and countless bath & body product brands (from Victoria’s Secret and The Body Shop to new DTC brands). The company’s ability to “reinvigorate its core product categories” is praised by analysts (apnews.com), but sustaining that momentum is an ongoing challenge. Any stagnation in product innovation or a failure to predict trends (e.g. shifts toward natural/clean ingredients or changes in young consumers’ preferences) poses a risk to sales. Additionally, brand fatigue could set in if customers tire of BBWI’s constant promotions (such as the popular “Buy 3, Get 3 Free” deals). In short, Bath & Body Works operates in a dynamic consumer discretionary space, and competition for shoppers’ attention – especially in the gift-giving season – remains intense.

– Inflation and Margin Pressures: Like many retailers, BBWI faces cost inflation in raw materials, labor, and freight. The company has cited inflationary pressure as a factor impacting results (www.sec.gov). While it has some pricing power (loyal customers will pay for favorite scents) and an efficient supply chain, higher costs can squeeze margins if not fully passed on. Notably, BBWI’s gross margin dipped in recent periods due to increased product costs and supply chain investments. Wage inflation is also relevant: Bath & Body Works employs a large store workforce and has committed to competitive pay and benefits to attract talent (www.sec.gov) (www.sec.gov). Rising labor costs, along with potential increases in sourcing costs (especially for ingredients like oils, packaging, etc.), could crimp profitability. If the U.S. consumer weakens, BBWI might be forced into deeper discounts that, combined with cost inflation, would pressure operating income. Thus far the company navigated inflation reasonably (2023 operating margin was ~17.3%, only slightly down from 18.2% in 2022 (www.sec.gov)), but persistent inflation or a recessionary environment is a clear risk to watch.

– Leverage and Interest Burden: As outlined earlier, Bath & Body Works’ debt load is sizable, and its annual interest expense (~$340+ million) is a fixed claim on cash flows (www.sec.gov). In benign conditions this is manageable (coverage ~3–4×), but in a downturn it becomes a heavier drag. The company’s bonds are sub-investment-grade; any deterioration in performance could lead to credit rating downgrades that complicate refinancing. With $314 million of 9.375% notes due in 2025, there’s refinancing risk if capital markets are tight or if BBWI’s equity remains undervalued (issuing equity to deleverage at these low P/E multiples would be costly dilution). Furthermore, while BBWI has over $1 billion in cash now (www.sec.gov) (www.sec.gov), it plans to use some of that for buybacks and operations. If it draws down cash and then hits a rough patch, liquidity could tighten quickly. Investors will be keen to see how the company addresses the 2025 maturity by the March 2026 timeframe – paying it off would substantially reduce interest costs, but might use up a lot of cash; refinancing would keep cash but lock in high interest outflows for longer. In sum, BBWI’s leverage amplifies other risks: it leaves less room for error in execution. This is a notable red flag relative to debt-free competitors and partly explains the stock’s discounted valuation.

– Governance and Leadership Concerns: A prominent red flag emerged in early 2023 when activist investor Third Point publicly criticized Bath & Body Works’ board for governance lapses. In a scathing letter, Third Point cited the “eye-popping” $18 million pay package granted to Chair (and then-interim CEO) Sarah Nash for seven months of service in 2022 (quoteddata.com) (quoteddata.com). The activist argued this “outsized pay package is a red flag for shareholders” and a sign of “massive governance failure”, noting it far exceeded what larger retailer Ulta paid its full-time CEO (quoteddata.com) (quoteddata.com). Third Point also alleged the board was insular and had rebuffed a highly qualified director candidate the hedge fund suggested (quoteddata.com) (quoteddata.com). These governance issues are serious because they suggest the potential for management/shareholder misalignment. Bath & Body Works’ Board responded by defending its decisions – for example, claiming that Nash’s compensation was largely equity meant to vest over three years (not solely interim CEO pay) (www.bbwinc.com) – and highlighting that it had refreshed the board with new independent directors and hired a new permanent CEO (Gina Boswell) in late 2022 (www.cnbc.com) (www.cnbc.com). The company’s February 2023 letter to shareholders listed steps taken to improve governance and performance (www.bbwinc.com) (www.bbwinc.com). Ultimately a proxy fight was averted as Third Point did not push to a vote, but shareholder activism remains a risk if performance falters. The episode is a reminder of potential red flags such as executive overpayment, transparency issues, or boardroom entrenchment. Investors should monitor if governance truly improves – e.g. aligning exec pay with results and ensuring a shareholder-friendly board – or if further activism could resurface by the next director election cycle. (The March 16, 2026 deadline may coincide with advance notice for nominations or other shareholder proposals at the 2026 annual meeting, emphasizing the timeliness of governance scrutiny.)

– Macro & Other Risks: Broader macroeconomic factors present ongoing risks. Consumer spending trends in a high-inflation or rising-interest-rate environment could weaken demand for BBWI’s discretionary products (lotions and candles are affordable luxuries but still non-essential in a tight budget). Any economic downturn or decline in consumer confidence can reduce store traffic and average ticket size. Additionally, Bath & Body Works is highly U.S.-centric – over 95% of sales are from North America – so its fortunes are tied closely to the U.S. economy. (International expansion is underway but contributed only ~$340 million of sales in 2023, about flat vs 2022 (www.sec.gov) (www.sec.gov).) Supply chain disruptions are another consideration: BBWI’s vertically-integrated supply chain largely within North America has been an advantage (www.sec.gov), but it still relies on global suppliers for some inputs. Any significant disruption in manufacturing or distribution (e.g. due to pandemics, geopolitical events, or transportation bottlenecks) could result in product shortages or higher costs. Finally, technology and cybersecurity pose modern risks – BBWI is investing in a multi-year IT transformation and handles millions of customer data points; a failure to successfully upgrade systems or a data breach could have financial and reputational ramifications (www.sec.gov) (www.sec.gov). While these are not immediate red flags, they are part of the risk mosaic that investors must keep in mind.

In summary, Bath & Body Works faces a combination of operational risks (seasonality, competition), financial risks (leverage), and governance concerns. Many of these are mitigated (to a degree) by the company’s strong brand loyalty and management’s actions (cost control, board refresh), but they underscore why the stock’s valuation is low. The impending March 2026 timeline heightens focus on these risk factors, as investors will expect clear action plans from management to address debt and sustain performance.

Open Questions & Considerations

As the “act now” deadline of March 16, 2026 nears, a few open questions remain for BBWI stakeholders:

– Can Growth be Reignited? Bath & Body Works’ recent top-line has been stagnant (fiscal 2023 sales were down ~2% to $7.43 billion (www.sec.gov), and 2024 is forecast roughly flat (apnews.com)). The company is working to find new growth drivers – expanding into product adjacencies, ramping up e-commerce and loyalty initiatives, and opening new stores off-mall while closing underperforming mall locations (www.sec.gov). It’s also slowly growing internationally via franchise partners (485 overseas stores, +14% YoY (www.sec.gov) (www.sec.gov)). However, it’s unclear if these moves can push BBWI back to solid growth or merely offset declines elsewhere. Will international markets contribute meaningfully to sales in coming years, or will cultural differences and competition abroad limit success (www.sec.gov) (www.sec.gov)? Can the brand’s domestic store refresh (with the White Barn candle shop concept) drive higher sales per square foot? These questions will determine if BBWI remains a low-growth cash cow or resumes a growth trajectory. A related point is product innovation cadence – management’s ability to consistently create “must-have” seasonal collections will directly impact same-store sales. Investors are waiting to see if recent positive momentum (e.g. Q3 2024’s +3% sales uptick (apnews.com)) can be sustained into 2025 and beyond.

– Margin Sustainability vs Expansion: BBWI enjoys rich margins (17–18% operating margin, ~44% gross margin). But can these be maintained or even improved? Cost pressures and a potentially promotional environment raise doubts, yet the company has margin opportunities through supply chain efficiencies and scaling newer channels. An open question is whether investments in logistics and IT will yield cost savings or merely add to SG&A – management’s execution here is crucial. Additionally, will BBWI’s pricing power hold if competitors discount heavily? Thus far the company has managed to pass through price increases selectively (e.g. charging a bit more for new premium collections), but if consumer sentiment weakens, it may need to lean on promotions. The outcome will influence BBWI’s earnings power in the next few years.

– Capital Allocation Priorities: With finite free cash flow, how will Bath & Body Works prioritize uses of cash after March 2026? The company has balanced debt reduction, share buybacks, and dividends in recent years, but trade-offs may sharpen. For example, if the stock stays low, will BBWI accelerate buybacks (taking advantage of undervaluation) even if that means slower debt paydown? Conversely, if credit markets are unfriendly, should BBWI temporarily curtail buybacks to retire the 2025–2027 notes and de-risk the balance sheet? Management’s stance will signal their confidence level in the business. Also, could there be strategic uses of cash (such as a bolt-on acquisition of a niche brand or investing in a new product line) that supersede purely financial uses? Thus far, no major acquisitions have been pursued, but the question remains open. Investors would also like clarity on the dividend growth policy – the payout has been flat at $0.20/qtr since 2022 (www.sec.gov) (www.sec.gov). With earnings and cash flow exceeding that, will the dividend be hiked in 2026, or is buyback viewed as the preferred route to return excess cash? The resolution of these allocation questions will shape BBWI’s shareholder value creation profile.

– Leadership and Governance Evolution: Now that a new CEO (Gina Boswell) has been in place for over a year, how is the strategic direction evolving? Gina Boswell’s background (coming from Unilever’s beauty/personal care division) suggests a focus on brand development and possibly broader product reach. Early signs, such as more product innovation and marketing tie-ins, are positive. But will the new leadership set bolder long-term targets (e.g. revenue growth %, margin expansion goals, or international footprint aims)? Furthermore, on governance: Bath & Body Works expanded its board with new members in 2022–2023, and Third Point’s campaign highlighted areas for improvement. Will the Board make additional governance changes (for instance, appointing an independent board chair separate from the prior interim CEO to alleviate conflict concerns)? The company’s letter in Feb 2023 emphasized it had the “right directors to maximize shareholder value” (www.bbwinc.com) (www.bbwinc.com), but investors will judge by outcomes. With the 2026 annual meeting on the horizon, shareholders will be looking for evidence that prior red flags have been addressed – including reasonable executive compensation (no repeats of outsized “Windfall” payouts) and responsiveness to shareholder input. An open question is whether Third Point or another activist will re-engage if the stock remains depressed, or if the Board’s refreshed composition has preemptively added the needed expertise (e.g. a retail-savvy director and a financial expert were added) (quoteddata.com) (quoteddata.com). Continued alignment of corporate governance with shareholder interests will be vital in convincing the market to re-rate BBWI’s valuation higher.

– External “Act Now” Factors: The very title urging “Act Now” hints at a time-sensitive catalyst. Aside from earnings, one such factor could be shareholder legal rights or actions. Occasionally, law firms announce investigation deadlines or class-action lawsuit cut-offs for shareholders who bought stock during specific periods – for instance, if there were allegations of securities law violations. As of now, there’s no public indication of such a class-action deadline specifically on March 16, 2026 for BBWI. But investors should stay informed on any legal proceedings or regulatory inquiries that might require attention. Additionally, proxy deadlines for shareholder proposals or nominating directors for the 2026 AGM likely fall around this time (often in March), meaning any discontented stakeholders would need to “act now” by that date. While speculative, these are areas to watch as the deadline nears. Essentially, stakeholders should ask: Is there any action I need to take by mid-March 2026 (voting, tendering shares, joining a litigation, etc.)? Staying vigilant ensures opportunities aren’t missed and rights are preserved.

Conclusion: Bath & Body Works stands at an important moment with its March 2026 catalyst approaching. The company has a strong core business with high margins and loyal customers, but it also carries notable baggage in the form of debt and questions about growth and governance. Its dividend is secure and generous, and the valuation is undeniably low – a combination that could yield attractive returns if execution is solid. However, the low valuation also reflects the risks: the market is effectively saying “show me” regarding renewed growth and prudent management. Investors considering BBWI should closely track the upcoming full-year earnings report (likely around March 16, 2026) and any related announcements (debt refinancing plans, capital allocation updates, or shareholder communications). That will be a key checkpoint to assess whether Bath & Body Works is truly on a “continued growth trajectory” as the Board proclaims (www.bbwinc.com), or if it faces more hurdles ahead. In any case, the convergence of financial deadlines and strategic crossroads means that now is a time for informed, active decision-making on BBWI. Act now, do the due diligence, and watch those dates – the next few weeks and months could be pivotal for Bath & Body Works’ investors.

Sources: Bath & Body Works SEC filings (10-K, 10-Q) (www.sec.gov) (www.sec.gov); Company investor relations (press releases, dividend history) (www.sec.gov) (www.sec.gov); AP News and credible financial media (apnews.com) (apnews.com); Third Point activist investor letter (via QuotedData) (quoteddata.com) (quoteddata.com); Bath & Body Works shareholder letter (Feb 2023) (www.bbwinc.com) (www.bbwinc.com); Dividend and stock data from Dividendpedia (dividendpedia.com).

For informational purposes only; not investment advice.